Business Context and Reporting Period
This Form 6-K is filed by Midatech Pharma PLC (noted as Biodexa Pharmaceuticals Plc in metadata) for the month of April 2019. The filing incorporates by reference a press release dated April 24, 2019, announcing audited financial results for the fiscal year ended December 31, 2018.
Key Financial Metrics
The provided text serves as a cover sheet and does not contain specific financial data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not available in this excerpt.
Material Changes
The filing text does not provide comparative financial data or details regarding material changes versus prior periods.
Guidance, Outlook, and Risks
Management commentary, future guidance, risk factors, and contingencies are not detailed in the provided text. The document solely references the existence of the audited results press release.
Investor Verification Checklist
- Verify the correct registrant name: The filing header identifies the company as Midatech Pharma PLC, while the metadata lists "Biodexa Pharmaceuticals Plc."
- Review the attached Exhibit 99.1 (Press Release) to obtain the actual audited financial figures for the year ended December 31, 2018.
- Confirm the company's reporting status as a Foreign Private Issuer filing under Form 20-F.